TY  - CONF

T1  - A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption.

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2004/07/15

AU  - Brown JE

AU  - McCloskey E

AU  - Dewar JA

AU  - Body JJ

AU  - Cameron DA

AU  - Purohit OPK

AU  - Harnett A

AU  - Tahtela R

AU  - Kurkilahti M

AU  - Coleman RE

ED  - 

VL  - 22

IS  - 14

SP  - 743S

EP  - 743S

Y2  - 2024/12/22

ER  -